Kursinformation
Aktuelle News
News Funktionen
Weitere Funktionen
20 September 2022
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing
13 Juli 2022
CEVEC Pharmaceuticals GmbH
CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients
7 September 2021
CEVEC Pharmaceuticals GmbH
CEVEC and UCB sign agreement for the use of CEVEC’s ELEVECTA(R) AAV manufacturing technology in Gene Therapy
27 Juli 2021
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH: CEVEC closes growth financing round to serve strong demand in viral vector technologies for cell and gene therapies
2 Februar 2021
CEVEC Pharmaceuticals GmbH
CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies
8 Januar 2021
CEVEC Pharmaceuticals GmbH
CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA(R) in gene therapy